DECODES 15 PhD Positions 2026: Closed Recruitment Guide

MSCA Doctoral Network · DECODES · RNA Splicing & Human Disease

DECODES — Deciphering the Splicing Code in Human Disease — recruited 15 Doctoral Candidates across Europe through a Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network. The official application deadline was 1 October 2026 at 23:45 Europe/Madrid, so this recruitment cycle is now closed.

15 PhD PositionsMSCA Doctoral Network36-Month ContractsRecruitment Closed
Status: CLOSED. EURAXESS lists 1 October 2026 at 23:45 Europe/Madrid as the final application deadline. The advertised interview window (10–31 October 2026) has passed. The notice anticipated candidate notifications on 15 November 2026; actual selection outcomes have not been independently confirmed. This is not an active application call.

DECODES MSCA Doctoral Network

DECODES is coordinated by the University of Santiago de Compostela and focuses on alternative RNA splicing and its role in human disease. The network links RNA biology with computational genomics, structural biology, disease modelling, RNA biochemistry, medicinal chemistry and pharmacological screening.

The programme recruited 15 doctoral researchers into an international, interdisciplinary and intersectoral training network combining academic, clinical and industrial research environments.

ProgrammeDECODES — Deciphering the Splicing Code in Human Disease
FundingHorizon Europe — Marie Skłodowska-Curie Actions Doctoral Networks
Grant Agreement101312753
CoordinatorUniversity of Santiago de Compostela
Positions15 Doctoral Candidate positions
Contract duration36 months
Current statusClosed
Advertisements

All 15 DECODES Research Projects

The 2026 call included 15 distinct doctoral projects across RNA biology, clinical genomics, structural biology, disease modelling and drug development. The table identifies every advertised project rather than grouping separate vacancies under one heading. These are historical descriptions of a closed recruitment call, not currently available jobs.

ProjectHostResearch focus
DC1University of Southampton, United KingdomMulti-omics for diagnosing unresolved rare diseases and identifying RNA therapeutic targets
DC2University of Basel, SwitzerlandComputational identification of disease-related splicing and polyadenylation isoforms
DC3Universitat Pompeu Fabra, SpainRegulatory splicing programmes in pancreatic beta cells and type 2 diabetes
DC4Gulbenkian Institute for Molecular Medicine / University of Lisbon, PortugalFunctional analysis of BRCA1/2 splice variants and candidate splicing modulators
DC5ETH Zurich, SwitzerlandTranscription–splicing coupling and biomolecular condensates
DC6Helmholtz Munich / Technical University of Munich, GermanyRBM-family splicing factors, branch-point selection and spliceosome assembly
DC7University of Santiago de Compostela, SpainSplicing changes in hepatic fibrosis and opportunities for modulation
DC8University of Santiago de Compostela, SpainSplicing dysregulation in demyelinating peripheral nerve disorders
DC9IMol Polish Academy of Sciences, PolandNuclear regulation of splicing factors during stem-cell activation
DC10Centre for Genomic Regulation / Universitat Pompeu Fabra, SpainCancer-related splicing networks and potential corrective strategies
DC11University of Southern Denmark, DenmarkRNA-binding proteins RBM10, RBM12 and RBM12B in health and disease
DC12University of Santiago de Compostela, SpainZFHX4 function in malignant peripheral nerve sheath tumours
DC13Leiden University Medical Center, NetherlandsAntisense oligonucleotides for ultra-rare neurodegenerative disorders
DC14AstraZeneca / University of Gothenburg, SwedenOligonucleotide chemistry and delivery for splice-switching therapeutics
DC15University of Santiago de Compostela, SpainPharmacological targeting of LSM2-8-associated splicing in nerve-sheath tumours

Prospective applicants to similar programmes should distinguish their research preparation by project: DC1 and DC2 involve multi-omics and computational analysis, DC5 and DC6 emphasise molecular or structural methods, while DC13–DC15 focus on therapeutic development. The official DECODES vacancy contains the full project objectives and supervisors.

Eligibility for the Closed 2026 Call

  • Academic qualification: a master’s degree or equivalent in molecular biology, biochemistry, genetics, biotechnology, biomedicine or another relevant field; project-specific preparation also mattered.
  • Doctoral status: applicants could not already hold a PhD. A researcher who had successfully defended a doctoral thesis but had not yet received the degree was also ineligible.
  • Nationality: candidates from any country were eligible, subject to the remaining requirements.
  • MSCA mobility: at recruitment, candidates could not have resided or carried out their main activity for more than 12 months during the preceding three years in the country of their recruiting organisation. Short visits such as holidays are generally excluded.
  • English: the call expected at least B2 proficiency. A recognised certificate was encouraged and could support the assessment, but the EURAXESS additional comments said it was not strictly mandatory for initial screening.
  • Secondments: candidates needed to be willing to relocate for research stays with academic or industrial network partners.

These are the published conditions for the 2026 recruitment. They must not be assumed to govern a later call without a fresh announcement.

Advertisements

Funding and Employment Terms

DECODES advertised 36-month doctoral employment contracts under the applicable MSCA Doctoral Networks rules and each recruiting organisation’s employment framework. EURAXESS identified the following monthly EU funding contributions:

Living allowance€4,010, before any applicable country correction coefficient
Mobility allowance€710
Family allowance€660, where eligible
Special-needs allowanceWhere applicable under programme rules
Advertised contracts36 months, with terms set by the recruiting employer

These amounts are not a guaranteed personal gross or net salary. The published values can cover salary and institutional employment costs, depending on the country and employer. Country corrections, deductions and other employment conditions affect the final remuneration. Candidates receiving an offer should obtain the host institution’s actual employment terms.

How Applicants Submitted Their 2026 Applications

Applications are closed. During the 2026 call, applicants could choose one, two or three positions and rank them in preference order. The central submission method was one PDF attachment by email to mscadn.decodes@usc.gal. This address is retained as the historical recruitment contact, not as an active application route.

The published application package consisted of:

  • Detailed academic CV
  • Motivation letter aligned to the selected research project(s)
  • Bachelor’s and master’s academic transcripts
  • English-proficiency evidence, if available; a B2 certificate was encouraged but not essential for initial screening

The required email subject was DECODES_1,5,8_YourSurnameName for an applicant ranking DC1, DC5 and DC8. Candidates were required to submit before 1 October 2026, 23:45 Europe/Madrid. This application format is provided to help readers understand the completed recruitment process; it is not a currently open submission instruction.

For a comparable future call, applicants should tailor their motivation statement to experimental or computational methods specified for each position and document previous research experience accurately. This is CareerAidHub’s editorial advice, not a separate DECODES recruitment criterion.

2026 Recruitment Calendar

Call opened25 August 2026
Application deadline1 October 2026, 23:45 Europe/Madrid — passed
Scheduled remote-evaluation results10 October 2026 — scheduled date passed
Scheduled interview window10–31 October 2026 — scheduled window passed
Expected candidate notification15 November 2026 — upcoming as of the 11 November review; outcome not confirmed
Advertised fellowship startsJanuary–December 2027, depending on the employer

The interview dates above are the published recruitment schedule; they do not independently establish that interviews took place or that offers have been made. No later general application cycle has been verified.

Advertisements

Frequently Asked Questions

Is DECODES accepting PhD applications now?

No. The published deadline for all 15 positions was 1 October 2026 at 23:45 Madrid time. No new programme-wide call has been verified.

Where can I find all 15 research projects?

The table above lists DC1–DC15 and their research areas. Full project descriptions and supervisors are in the official EURAXESS vacancy.

Was a formal English test score mandatory?

B2 proficiency was expected. A recognised certificate was encouraged but, according to the official additional comments, not strictly required for initial screening.

How much did the positions pay?

EURAXESS listed MSCA allowance contributions rather than uniform take-home salaries. Final terms depended on the recruiting employer and country.

When were candidates expected to hear back?

The recruitment schedule anticipated notifications on 15 November 2026. Actual outcomes are not verified here.

Official EURAXESS Source

StatusClosed
Deadline1 October 2026, 23:45 Europe/Madrid
Positions15
FundingHorizon Europe — MSCA Doctoral Networks
Last verified11 November 2026

Sources checked 11 November 2026: DECODES recruitment notice (EURAXESS); EURAXESS programme summary; European Commission CORDIS project record. Official source dates are historical; consult the publisher for any future announcements.

Scroll to Top